Family Medicine and Community Health Journal volume 6, issue number 1 publishes

February 24, 2018

Beijing, February 16, 2018: The February 2018 issue includes an editorial, five original research articles and two Qualitative Exploration articles addressing various topics in family medicine in both China and internationally.

The first featured article in this issue is an original research article entitled "Type 2 diabetes: Challenges facing GPs" by authors Lili Huo and Jonathan E. Shaw. China faces a huge task in managing the large numbers of people with diabetes. General practitioners (GPs) are in a privileged position to provide first contact and continuing care for most diabetic patients. However, the GP system in China is still in its infancy and faces a range of challenges, such as a shortage of health care providers, GPs' poor adherence to guideline recommendations, patients' poor adherence to treatment, and lack of access to health care. In this article we describe the challenges that GPs in China are struggling with and some of the management and organizational approaches that have been shown to be successful in tackling diabetes and similar chronic diseases.

The second featured article is an original research article entitled "Chronic heart failure: Role of the GP in management" by Leon Piterman, Hui Yang and Zhaoxia Yin. In keeping with the global rise in the prevalence of chronic and noncommunicable disease, the prevalence of chronic heart failure (CHF) is increasing globally, with estimates of 10% of the population older than 75 years affected in developed countries, despite improvements in the management of cardiovascular disease more generally. This article discusses current management of CHF, illustrating the important role played by the GP in coordinating care. Management includes nonpharmacological as well as pharmacological treatment, and self-care with careful monitoring of salt and fluid intake as well as regular weight measurement. Care planning and team-based care are essential in managing patients with CHF, who often have concurrent multimorbidity and are receiving polypharmacy.Other articles published in the issue include:

Editorial


Chronic non-communicable disease

Leon Piterman, Hui Yang

Original Research


Offshore teaching in chronic disease management: The Monash-Shenzhen experience

Leon Piterman, Hui Yang, Grant Blashki

General practice training in China: A multimodal experiential program provided by Australian educators

Grant Blashki, Hui Yang, Leon Piterman

Chronic disease in a digital health environment

Christopher Pearce

Qualitative Exploration

A qualitative exploration of GPs' perspectives on managing chronic nonspecific musculoskeletal pain in Australian general practice - a focus group study

Manasi Gaikwad, Simon Vanlint, Paul Aylward, Nigel Stocks

Assessing the implementation of the family care team in the district health system of health region 2, Thailand

Nithra Kitreerawutiwong, Sunsanee Mekrungrengwong, Artitaya Wongwonsin, Chakkraphan Phetphum

FMCH is available on the IngentaConnect platform and at Family Medicine and Community Health. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. FMCH is indexed in the ESCI, EBSCO, OCLC, Primo Central (Ex Libris), Scopus, Sherpa Romeo, Ulrichsweb, DOAJ, WPRIM, NISC (National Information Services Corporation) and Index Copernicus Databases. Follow FMCH on Twitter @FMCHJournal; or Facebook. http://www.ingentaconnect.com/content/cscript/fmch/2016/00000004/00000004

Full bibliographic information

Volume 6, Number 1

Family Medicine and Community Health

ISSN 2305-6983 (Print); ISSN: 2009-8774 (Online)
-end-


Cardiovascular Innovations and Applications

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.